David Lasecki
Keine laufenden Positionen mehr
Profil
David Lasecki worked as a Senior Director-Oncology Sales at Heron Therapeutics, Inc. and as a Chief Commercialization Officer at GenomOncology LLC.
He also briefly worked as an Executive Director-Strategic Alliances at Cellectar Biosciences, Inc. Mr. Lasecki completed his undergraduate degree at the University of Mount Union.
Ehemalige bekannte Positionen von David Lasecki
| Unternehmen | Position | Ende |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Corporate Officer/Principal | 01.11.2022 |
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
GenomOncology LLC
 GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | - |
Ausbildung von David Lasecki
| University of Mount Union | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| HERON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
GenomOncology LLC
GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Technology Services |
